519 related articles for article (PubMed ID: 12370407)
1. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
2. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
3. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
[TBL] [Abstract][Full Text] [Related]
4. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
Ji H; Shen XD; Gao F; Busuttil RW; Zhai Y; Kupiec-Weglinski JW
Transplantation; 2011 May; 91(10):1075-81. PubMed ID: 21427633
[TBL] [Abstract][Full Text] [Related]
5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
6. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
7. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
8. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
[TBL] [Abstract][Full Text] [Related]
9. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
Ferrer IR; Wagener ME; Song M; Ford ML
PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369
[TBL] [Abstract][Full Text] [Related]
10. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
11. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
[TBL] [Abstract][Full Text] [Related]
12. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
13. Critical role of OX40 in CD28 and CD154-independent rejection.
Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
[TBL] [Abstract][Full Text] [Related]
15. CD44/CD70 blockade and anti-CD154/LFA-1 treatment synergistically suppress accelerated rejection and prolong cardiac allograft survival in mice.
Shao W; Yan G; Lin Y; Chen J; Dai H; Wang F; Xi Y; Thorlacius H; Qi Z
Scand J Immunol; 2011 Nov; 74(5):430-7. PubMed ID: 21707692
[TBL] [Abstract][Full Text] [Related]
16. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
Vu MD; Clarkson MR; Yagita H; Turka LA; Sayegh MH; Li XC
J Immunol; 2006 Feb; 176(3):1394-401. PubMed ID: 16424166
[TBL] [Abstract][Full Text] [Related]
17. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation.
Zhai Y; Shen XD; Gao F; Coito AJ; Wasowska BA; Salama A; Schmitt I; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2002 Aug; 169(3):1270-6. PubMed ID: 12133948
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
Coley SM; Ford ML; Hanna SC; Wagener ME; Kirk AD; Larsen CP
J Immunol; 2009 Jan; 182(1):225-33. PubMed ID: 19109153
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
van Maurik Av; Herber M; Wood KJ; Jones ND
J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
[TBL] [Abstract][Full Text] [Related]
20. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
